Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients

Journal of Pharmacology and Experimental Therapeutics

Volumn 271, Issue 1, 1994, Pages 549-556

  Thummel, K E ^a   Shen, D D ^a   Podoll, T D ^a   Kunze, K L ^a   Trager, W F ^a   Hartwell, P S ^a   Raisys, V A ^a   Marsh, C L ^a   McVicar, J P ^a   Barr, D M ^a   Perkins, J D ^a   Carithers Jr , R L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYMIDAZOLAM; CYCLOSPORIN; CYTOCHROME P450; MIDAZOLAM;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG HYDROXYLATION; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; LIVER TRANSPLANTATION; PRIORITY JOURNAL;

CYCLOSPORINE; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; HUMAN; LIVER; LIVER TRANSPLANTATION; METABOLIC CLEARANCE RATE; MIDAZOLAM; MIXED FUNCTION OXYGENASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028114619     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)